Synecco’s manufacturing facility is in Ireland’s County Clare near Whitegate. [Photo courtesy of Synecco]
Founded in 2004, Galway, Ireland-based Synecco serves the Irish market and mainland Europe with a design center in County Galway and a manufacturing facility in County Clare. The firm is FDA-registered and also has a presence in China, Arterex said.
“Synecco’s capabilities in design and development, including in structural heart technologies, injection molding, and assembly expands the breadth of our product offering in Europe,” Arterex CEO Jeff Goble said in a news release. “Synecco is a trusted partner for many leading medtech companies, and Arterex brings increased resources to support Synneco’s accelerated growth.”
Synecco’s manufacturing operations include extendable cleanroom and non‑cleanroom production, an in‑house metrology laboratory and tool maintenance workshop.
“We’re excited to embark on this strategic partnership to create new opportunities,” Synecco Managing Director Tony Doherty said in the release. “Arterex’s global resources and dedication to innovation, quality, and collaboration aligns perfectly with our vision for the future.”
London-based private equity firm Investindustrial launched Arterex in 2022 after combining Formula Plastics, Kabo, Luc & Bel and ModenPlast. Since then, Scottsdale, Arizona-based Arterex has purchased NextPhase, Micromold, Phoenix, Adroit and Xponent Global.
